COMPANY PROFILE // THE 014 REPORT
Centessa Pharmaceuticals plc
Formerly: Centessa Pharmaceuticals Ltd
Assembled from 2 government sources in 2.5 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2026-06-24 (last 24 months).
- Amber4 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-06-24: a pattern of leadership change.
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
Centessa Pharmaceuticals plc is an SEC-registered operating company in pharmaceutical preparations, incorporated in United Kingdom, based in Altrincham, Cheshire, United Kingdom.[source] It reported revenue of $15.0 million for the fiscal year ended 2025-12-31.[source] It has filed 92 documents with the SEC in the last 12 months; the latest is a SCHEDULE 13G/A, filed 2026-08-14.[source] Seraphix flags 2 items from these records: 8-K Item 3.01 filed; 4 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-06-24.[source]
- red0
- amber2
- info0
- CLEAR26
- POSSIBLE MATCH0
- MATCH0
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001847903 | source |
| EIN | 00-0000000 | source |
| Business address (SEC) | 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE, X0, WA14 2DT | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-31 · in 129 days · Next 10-K due (period ended 2026-12-31; <br>Emerging growth company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 174 days · Next 10-Q due (period ended 2027-03-31; <br>Emerging growth company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.
Peers, each with its 014
- PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
- Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
- ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
- ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
- TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
- NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
- Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
- Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
- SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
- Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
- UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
- Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-07-06 filing 15-12G · SEC EDGAR
- 2026-06-26 filing SCHEDULE 13D/A · SEC EDGAR
- 2026-06-24 filing SCHEDULE 13D · SEC EDGAR
- 2026-06-24 filing S-8 POS · SEC EDGAR
- 2026-06-24 filing S-8 POS · SEC EDGAR
- 2026-06-24 filing S-8 POS · SEC EDGAR
- 2026-06-24 filing S-8 POS · SEC EDGAR
- 2026-06-24 filing S-8 POS · SEC EDGAR
- 2026-06-24 filing S-8 POS · SEC EDGAR
- 2026-06-24 filing POSASR · SEC EDGAR
- 2026-06-24 filing 25-NSE · SEC EDGAR
- 2026-06-24 officer change 8-K items 1.02,2.01,3.01,3.03,5.01,5.02,8.01,9.01 · SEC EDGAR
- 2026-06-12 filing 8-K items 5.07,8.01 · SEC EDGAR
- 2026-05-22 filing 8-K items 8.01 · SEC EDGAR
- 2026-05-07 filing DEFM14A · SEC EDGAR
- 2026-05-05 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-04-29 filing ARS · SEC EDGAR
- 2026-04-29 filing Proxy statement · SEC EDGAR
- 2026-04-17 filing PREM14A · SEC EDGAR
- 2026-04-13 filing DEFA14A · SEC EDGAR
- 2026-03-31 filing DEFA14A · SEC EDGAR
- 2026-03-31 filing DEFA14A · SEC EDGAR
- 2026-03-31 filing DEFA14A · SEC EDGAR
- 2026-03-31 filing DEFA14A · SEC EDGAR
- 2026-03-31 filing S-8 · SEC EDGAR
- 2026-03-31 filing Annual report (10-K) · SEC EDGAR
- 2026-03-31 filing DEFA14A · SEC EDGAR
- 2026-03-31 filing 8-K items 1.01,7.01,9.01 · SEC EDGAR
- 2026-03-31 filing DFAN14A · SEC EDGAR
- 2026-03-26 filing 144 · SEC EDGAR
168 earlier entries
- 2026-03-26 filing 144
- 2026-03-17 filing 144
- 2026-03-16 filing 144
- 2026-03-13 filing 144
- 2026-03-13 filing 144
- 2026-02-13 officer change 8-K items 5.02
- 2026-01-30 filing 144
- 2026-01-21 filing 144
- 2026-01-07 officer change 8-K/A items 5.02,9.01
- 2026-01-02 filing 144
- 2025-12-11 officer change 8-K items 5.02,7.01,9.01
- 2025-12-09 filing 144
- 2025-12-08 filing 144
- 2025-11-28 filing SCHEDULE 13D/A
- 2025-11-24 filing 8-K items 8.01,9.01
- 2025-11-24 filing 424B5
- 2025-11-17 filing SCHEDULE 13D/A
- 2025-11-17 filing 144
- 2025-11-17 filing 144
- 2025-11-13 filing 8-K items 1.01,8.01,9.01
- 2025-11-13 filing 424B5
- 2025-11-12 filing 144
- 2025-11-12 filing 424B5
- 2025-11-05 filing Quarterly report (10-Q)
- 2025-11-05 filing 8-K items 2.02,7.01,9.01
- 2025-10-27 filing 144/A
- 2025-10-27 filing 144
- 2025-10-15 filing 144
- 2025-09-24 filing 144
- 2025-09-16 filing 144
- 2025-09-15 filing 144
- 2025-09-10 filing 144
- 2025-09-10 filing 144
- 2025-09-09 filing 144
- 2025-09-09 filing 144
- 2025-09-09 filing 144
- 2025-08-15 filing 144
- 2025-08-12 filing Quarterly report (10-Q)
- 2025-08-12 filing 8-K items 2.02,9.01
- 2025-07-29 filing 144
- 2025-07-25 filing 144
- 2025-07-21 filing 144
- 2025-07-17 filing 144
- 2025-07-17 filing 144
- 2025-07-15 filing 144
- 2025-06-25 filing 144
- 2025-06-25 filing 144
- 2025-06-24 filing 144
- 2025-06-20 filing 144
- 2025-06-20 filing 144
- 2025-06-20 filing 8-K items 5.07
- 2025-06-17 filing 8-K items 8.01,9.01
- 2025-05-29 officer change 8-K items 5.02,9.01
- 2025-05-28 filing DEFA14A
- 2025-05-27 filing 144
- 2025-05-20 filing 144
- 2025-05-14 filing Quarterly report (10-Q)
- 2025-05-14 filing 8-K items 2.02,9.01
- 2025-05-06 filing ARS
- 2025-05-06 filing Proxy statement
- 2025-04-28 filing 144
- 2025-04-25 filing 144
- 2025-04-25 filing 144
- 2025-04-22 filing PRE 14A
- 2025-04-22 filing 144
- 2025-04-21 filing 144
- 2025-03-25 filing 144
- 2025-03-24 filing S-8
- 2025-03-24 filing Annual report (10-K)
- 2025-03-24 filing 8-K items 2.02,9.01
- 2025-03-20 filing 144
- 2025-03-17 filing 144
- 2025-03-17 filing 144
- 2025-02-25 filing 144
- 2025-02-21 filing 8-K items 1.01
- 2025-02-20 filing 144
- 2025-02-18 filing 144
- 2025-02-14 filing 10-Q/A
- 2025-02-10 filing 144
- 2025-02-07 filing 144
- 2025-02-03 filing 144
- 2025-02-03 filing 144
- 2025-01-27 filing 144
- 2025-01-21 filing 144
- 2025-01-15 filing 144
- 2025-01-08 filing 8-K items 7.01,9.01
- 2024-12-30 filing 8-K items 1.01,1.02,2.03,9.01
- 2024-12-26 filing 144
- 2024-12-20 filing 144
- 2024-12-17 filing 144
- 2024-12-16 filing 144
- 2024-12-16 filing 144
- 2024-12-13 filing 144
- 2024-12-06 filing 144
- 2024-11-25 filing 144
- 2024-11-25 filing 144
- 2024-11-22 filing 144
- 2024-11-21 filing 144
- 2024-11-20 filing 144
- 2024-11-13 filing 144
- 2024-11-12 filing Quarterly report (10-Q)
- 2024-11-12 filing 8-K items 2.02,7.01,9.01
- 2024-10-25 filing 144
- 2024-10-23 filing 144
- 2024-10-22 filing 144
- 2024-10-21 filing 144
- 2024-10-18 filing 10-Q/A
- 2024-09-25 filing 144
- 2024-09-20 filing 144
- 2024-09-13 filing 424B5
- 2024-09-13 filing 8-K items 1.01,8.01,9.01
- 2024-09-11 filing 424B5
- 2024-09-11 filing S-3ASR
- 2024-09-10 filing 144
- 2024-09-10 filing 144
- 2024-09-10 filing 8-K items 7.01,8.01,9.01
- 2024-09-09 filing 144
- 2024-08-23 filing 144
- 2024-08-23 filing 144
- 2024-08-22 filing 144
- 2024-08-22 filing 144
- 2024-08-21 filing 144
- 2024-08-20 filing 144
- 2024-08-13 filing Quarterly report (10-Q)
- 2024-08-13 filing 8-K items 2.02,9.01
- 2024-06-25 filing 8-K items 5.07
- 2024-06-10 officer change 8-K items 5.02,7.01,9.01
- 2024-05-21 filing DEFA14A
- 2024-05-13 filing Quarterly report (10-Q)
- 2024-05-13 filing 8-K items 2.02,9.01
- 2024-05-09 filing ARS
- 2024-05-09 filing Proxy statement
- 2024-04-26 filing PRE 14A
- 2024-04-25 filing 424B5
- 2024-04-24 filing 8-K items 1.01,2.02,8.01,9.01
- 2024-04-23 filing 424B5
- 2024-04-22 filing 8-K items 7.01,8.01,9.01
- 2024-03-28 filing S-8
- 2024-03-28 filing Annual report (10-K)
- 2024-03-28 filing 8-K items 2.02,9.01
- 2024-03-25 filing 144
- 2024-02-09 filing 8-K items 7.01,9.01
- 2024-02-01 filing 144
- 2024-01-09 filing 8-K items 7.01,9.01
- 2023-12-11 filing 8-K items 7.01,9.01
- 2023-11-13 filing Quarterly report (10-Q)
- 2023-11-13 filing 8-K items 2.02,9.01
- 2023-10-25 filing 8-K items 7.01,8.01,9.01
- 2023-09-20 filing 144
- 2023-09-01 filing 144
- 2023-08-24 filing 8-K items 8.01,9.01
- 2023-08-14 filing Quarterly report (10-Q)
- 2023-08-14 filing 8-K items 2.02,7.01,9.01
- 2023-08-01 filing 144
- 2023-07-10 filing 8-K items 7.01,8.01,9.01
- 2023-07-03 filing 144
- 2023-06-22 filing 8-K items 5.07
- 2023-06-09 filing 8-K items 7.01,9.01
- 2023-06-01 filing 144
- 2023-05-24 filing 144
- 2023-05-23 filing DEFA14A
- 2023-05-22 filing 8-K items 7.01,8.01,9.01
- 2023-05-15 filing Proxy statement
- 2023-05-15 filing ARS
- 2023-05-12 filing Quarterly report (10-Q)
- 2023-05-12 filing 8-K items 2.02,9.01
- 2023-05-01 filing 144
- 2021-05-24 name change Name changed from Centessa Pharmaceuticals Ltd
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-07-06 (older) 15-12G filed
- 2026-06-24 (older) S-8 POS filed
- 2026-06-24 (older) S-8 POS filed
- 2026-06-24 (older) S-8 POS filed
- 2026-06-24 (older) S-8 POS filed
- 2026-06-24 (older) S-8 POS filed
- 2026-06-24 (older) S-8 POS filed
- 2026-06-24 (older) POSASR filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-22; the colour is also written out in words.
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- No listing symbol is held for this company.
- Open in
Open in…
Insider trades
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
0 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1847903 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| CUSIP | 152309100 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001847903 | SEC EDGAR |
The company table did not answer, so only the identifiers carried on the SEC record are shown.
Next: reload in a minute, or open the record page.
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $15,000,000 | 2025-12-31 | 10-K, XBRL Revenues | as filed | 2026-11-22 10:01 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | -$197,532,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-22 10:01 UTC | Report an error |
| Total assets (at 2025-12-31) | $687,495,000 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-22 10:01 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $526,863,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-22 10:01 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $61,299,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-22 10:01 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-08-14 | SEC EDGAR company profile | as filed | 2026-11-22 10:01 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-08-14 | SEC EDGAR company profile | as filed | 2026-11-22 10:01 UTC | Report an error |
| State of incorporation | X0 | 2026-08-14 | SEC EDGAR company profile | as filed | 2026-11-22 10:01 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-08-14 | SEC EDGAR company profile | as filed | 2026-11-22 10:01 UTC | Report an error |
| Business address | 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE, X0, WA14 2DT | 2026-08-14 | SEC EDGAR company profile | as filed | 2026-11-22 10:01 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | -$193,817,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-22 10:01 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $371,000 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-22 10:01 UTC | Report an error |
| Long-term debt (at 2025-12-31) | $110,095,000 | 2025-12-31 | 10-K, XBRL LongTermDebt | as filed | 2026-11-22 10:01 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $8,286,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-22 10:01 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-03-31, filed 2026-05-05 · accession 0001847903-26-000049
Old data: the newest 10-Q or 10-K in SEC company facts has no later XBRL values.
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | 3 months ended 2026-03-31 | 10-Q | 2026-05-05 | 0001847903-26-000049 | 2026-11-22 10:01 UTC | Report an error |
| Net income (loss) | -$79,241,000 | 3 months ended 2026-03-31 | 10-Q | 2026-05-05 | 0001847903-26-000049 | 2026-11-22 10:01 UTC | Report an error |
| Interest expense | $2,731,000 | 3 months ended 2026-03-31 | 10-Q | 2026-05-05 | 0001847903-26-000049 | 2026-11-22 10:01 UTC | Report an error |
| Cash and cash equivalents | $62,431,000 | at 2026-03-31 | 10-Q | 2026-05-05 | 0001847903-26-000049 | 2026-11-22 10:01 UTC | Report an error |
| Debt due in the next 12 months | $0 | at 2026-03-31 | 10-Q | 2026-05-05 | 0001847903-26-000049 | 2026-11-22 10:01 UTC | Report an error |
| Debt due in year 2 | $115,500,000 | at 2026-03-31 | 10-Q | 2026-05-05 | 0001847903-26-000049 | 2026-11-22 10:01 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-07-06 Filing 15-12G filed
- 2026-06-24 Filing S-8 POS filed
- 2026-06-24 Filing S-8 POS filed
- 2026-06-24 Filing S-8 POS filed
- 2026-06-24 Filing S-8 POS filed
- 2026-06-24 Filing S-8 POS filed
- 2026-06-24 Filing S-8 POS filed
- 2026-06-24 Filing POSASR filed
- 2026-06-24 Filing 25-NSE filed
- 2026-06-24 Filing 8-K filed: Item 1.02 agreement terminated; Item 2.01 acquisition or disposition; Item 3.01 delisting notice; Item 3.03 rights of holders modified; Item 5.01 change in control; Item 5.02 officer or director change; Item 8.01 other event; Item 9.01 exhibits
- 2026-06-12 Filing 8-K filed: Item 5.07 shareholder vote; Item 8.01 other event
- 2026-05-22 Filing 8-K filed: Item 8.01 other event
- 2026-05-07 Filing DEFM14A filed
- 2026-05-05 Filing 10-Q filed
- 2026-04-29 Filing ARS filed
- 2026-04-29 Filing DEF 14A filed
- 2026-04-17 Filing PREM14A filed
- 2026-04-13 Filing DEFA14A filed
- 2026-03-31 Filing DEFA14A filed
- 2026-03-31 Filing DEFA14A filed
- 2026-03-31 Filing DEFA14A filed
- 2026-03-31 Filing DEFA14A filed
- 2026-03-31 Filing S-8 filed
- 2026-03-31 Filing 10-K filed
- 2026-03-31 Filing DEFA14A filed
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1847903.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001847903. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.